Houston、TXにおける過体重の臨床試験
Houstonとその周辺地域（約30マイル以内）の拠点で、過体重に関する33件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
被験者募集中第2相
- Juno Research /ID# 282413, Houston
- PlanIt Research /ID# 282204, Houston
- JCCT - Juno Bellaire /ID# 282263, Bellaire · 7マイル先
AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
被験者募集中第3相
- PlanIt Research, PLLC, Houston
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
被験者募集中第3相
- DM Clinical, Houston
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
被験者募集中第3相
- Houston Research Institute, Houston
- The Endocrine Center, Houston
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
被験者募集中第3相
- Biopharma Informatic, LLC, Houston
- Care Access - Houston - Clinical Trials Center by Walmart & Care Access, Houston
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
被験者募集中第3相
- PlanIt Research, LLC (Monitoring Room), Houston
- PlanIt Research, LLC, Houston
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
被験者募集中第3相
- Research Site, Houston
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
被験者募集中第3相
- McGovern Medical School, Houston
- Texas Childrens Hospital, Houston
- Dynamed Clinical Research, LP d/b/a DM Clinical Research, Houston
- 他1件
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
被験者募集中第3相
- Juno Research, Houston
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
被験者募集中第3相
- Juno Research, Houston
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
被験者募集中第3相
- Research Site, Houston
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
被験者募集中第3相
- Biopharma Informatic, LLC, Houston
- Cardiovascular Specialists of Willowbrook, Houston
- PlanIt Research, PLLC, Houston
- 他2件
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
被験者募集中第3相
- The University of Texas Health Science Center at Houston, Bellaire · 7マイル先
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
被験者募集中第3相
- Care Access - Houston, Houston
- JCCT - Juno Bellaire Site, Bellaire · 7マイル先
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
被験者募集中第2相
- PlanIt Research, PLLC, Houston
Semaglutide for Post-Smoking Cessation Weight Management
被験者募集中第2相健康なボランティア歓迎
- The University of Texas Health Science Center at Houston, Houston
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
被験者募集中第3相
- AURORA-2 Clinical Site, Houston
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
被験者募集中第3相
- HRI ? Medical Center, LLC, Houston
- Juno Research, LLC, Houston
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
被験者募集中第2相
- Juno Research, Houston
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
被験者募集中第3相
- Elevate Clinical, Houston
- Houston Research Institute, Houston
- Bellaire Clinical Research, LLC, Bellaire · 7マイル先
AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
被験者募集中第3相
- Houston Pulm Med Res Network, Houston
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
被験者募集中第3相健康なボランティア歓迎
- ACCOMPLISH-2 Research Site, Houston
- ACCOMPLISH-2 Research Site, Houston
AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
被験者募集中第3相
- Houston Pulm Med Res Network, Houston
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
被験者募集中第2相
- PlanIt Research, PLLC, Houston
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
被験者募集中第2相
- Biopharma Informatic, LLC, Houston
- PlanIt Research, PLLC, Houston
- Research Physicians Network, LLC, Houston
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
被験者募集中第4相
- Center for Clinical Studies, Houston
- Bellaire Dermatology Associates, Bellaire · 7マイル先
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
被験者募集中第3相
- JCCT- Juno Northwest Houston, Houston
- Biopharma Informatic, LLC, Houston
- Johnson County Clinical Trials Juno Bellaire, Bellaire · 7マイル先
Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
被験者募集中第3相
- Kailera Clinical Site, Bellaire · 7マイル先
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
被験者募集中第3相
- JCCT- Juno Northwest Houston, Houston
- Johnson County Clinical Trials Juno Bellaire, Bellaire · 7マイル先
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
被験者募集中第3相
- Biopharma Informatic, LLC, Houston
- Research Physicians Network, LLC, Houston
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
被験者募集中第3相
- Research Site, Houston
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
被験者募集中第3相
- ACCOMPLISH-1 Research Site, Houston
- ACCOMPLISH-1 Research Site, Houston
Metformin IN Asthma for Overweight and Obese Individuals (MINA)
被験者募集中第2相
- Baylor College of Medicine, Houston
他の都市における過体重の試験
- San Antonio, TX34件の研究
- Chicago, IL28件の研究
- Orlando, FL27件の研究
- Las Vegas, NV23件の研究
- Miami, FL23件の研究
- Atlanta, GA20件の研究
- Dallas, TX20件の研究
- New York City, NY19件の研究
- Jacksonville, FL19件の研究
- Washington, DC19件の研究
- Austin, TX18件の研究
- Baltimore, MD17件の研究
Houstonにおける他の研究
- 非小細胞肺癌145件の研究
- 乳がん126件の研究
- がん（全種類）121件の研究
- 転移性癌104件の研究
- 大腸癌102件の研究
- 卵巣がん89件の研究
- 急性骨髄性白血病85件の研究
- 肺がん78件の研究
- 前立腺がん76件の研究
- 子宮内膜がん68件の研究
- 膵臓がん61件の研究
- 悪性黒色腫59件の研究
ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。